Medical-Bioethical Mediation as a Potential Governance Innovation for Sustainable, Efficient, and Resilient Healthcare Systems.

BACKGROUND/

OBJECTIVES

Healthcare systems increasingly operate through dense networks of clinicians, managers, public health authorities, institutions, and communities. Disagreement is no longer confined to bedside decisions; it also affects coordination, legitimacy, and implementation at system level. Bioethics, administrative governance, and consultation processes address important parts of this problem, but they do not by themselves provide a dedicated process for handling persistent disagreement, mistrust, and competing values across actors and institutions. This paper proposes medical-bioethical mediation as a potential governance innovation for sustainable, efficient, and resilient healthcare systems.

METHODS

This is a conceptual framework paper based on an integrative synthesis of selected literature in clinical bioethics mediation, medical mediation, public health ethics, deliberative and participatory governance, trust, inter-organizational coordination, health governance, and health system resilience. It does not report empirical research or a systematic review.

RESULTS

The proposed population-level framework is organized around seven linked components: conflict identification, stakeholder mapping, ethical issue clarification, mediation, negotiated solutions, implementation, and feedback and learning. These components form three broader moments: diagnosis, mediated deliberation, and implementation with learning. The framework identifies mechanisms through which mediation may affect health system governance, including conflict transformation, structured ethical deliberation, participation, trust-building, coordination, and adaptive learning. Illustrative scenarios include resource allocation, inter-organizational coordination, public health restrictions, vaccine mistrust, and system reform. The framework is proposed as a hypothesis-generating governance model rather than as a tested intervention.

CONCLUSIONS

Medical-bioethical mediation should be considered beyond the bedside as a possible system-level governance approach. Its potential value lies in helping health systems manage recurring ethical and institutional conflict more constructively and may strengthen the conditions for legitimacy, coordination, implementation, and learning. Its potential contribution should be understood as plausible but unproven at population level and should be evaluated through pilot implementation, economic analysis, and comparative case research.